Market Overview

InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6

Share:

Conference Call Scheduled for 8am Eastern Time

TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) --  InspireMD, Inc. (NYSE:NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 6, 2018, to discuss financial results for the three and nine months ended September 30, 2018, and provide a corporate update.

Conference Call & Webcast:
Tuesday, November 6 @ 8:00am Eastern Time
Within the US: 877-451-6152
Outside the US: 201-389-0879
Conference ID: 13683949 
Webcast: http://public.viavid.com/index.php?id=131700
 
Replays, Available through November 20:
Domestic:   844-512-2921
International:   412-317-6671
Replay PIN:   13683949

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.

InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.

Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com 

Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
jeremy@lifesciadvisors.com

 

inspiremd.png

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com